Bausch Health Pilot Study Shows Improved Cirrhosis Care Adherence
(RTTNews) - Bausch Health Companies Inc. (BHC, BHC.TO) and its gastroenterology unit Salix Pharmaceuticals, announced on Monday that a six-month pilot study of a standardized clinical pathway for Cirrhosis management improved adherence to guideline-based monitoring and treatment
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.